IL17A and COVID-19: Evidence suggests that it plays an important role in the pathogenesis of COVID-19 through the release of IL-17 and GM-CSF, promotion of neutrophil migration, induction of Th2 and inhibition of Th1 differentiation, and downregulation of Treg response (44).